RemeGen Co., Ltd. (REGMF)
USD 1.5
(0.0%)
USD 1.5
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 822.99 Million CNY | 65.31% |
| 2022 | 497.83 Million CNY | -63.31% |
| 2021 | 1.35 Billion CNY | 12158.67% |
| 2020 | -11.25 Million CNY | -81.98% |
| 2019 | -6.18 Million CNY | -358.79% |
| 2018 | 2.38 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 34.97 Million USD | -100.0% |
| 2024 Q3 | 53.14 Million USD | 24.82% |
| 2024 Q2 | 37.11 Million USD | 0.0% |
| 2023 Q3 | 275.25 Million CNY | 1271.1% |
| 2023 Q1 | 14.54 Million USD | -90.42% |
| 2023 FY | 822.99 Million CNY | 65.31% |
| 2023 Q4 | 27.33 Million USD | -90.07% |
| 2023 Q2 | 20.07 Million USD | 38.03% |
| 2022 Q3 | 164.79 Million CNY | 1023.54% |
| 2022 Q2 | 14.66 Million USD | 370.87% |
| 2022 Q1 | 3.11 Million USD | -98.48% |
| 2022 FY | 497.83 Million CNY | -63.31% |
| 2022 Q4 | 151.77 Million CNY | -7.9% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 1.35 Billion CNY | 12158.67% |
| 2021 Q4 | 204.95 Million USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | -11.25 Million CNY | -81.98% |
| 2020 Q4 | 136.39 Thousand USD | 0.0% |
| 2019 FY | -6.18 Million CNY | -358.79% |
| 2018 FY | 2.38 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -590.967% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 257682.463% |
| Qrons Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -466027.096% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -6930.531% |
| BioStem Technologies, Inc. | 15.42 Million USD | -5235.508% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 662464.086% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 1705468.947% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 89.115% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 3290.147% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -8463.042% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -585660.854% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 33743191.431% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -5386.992% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -26530976.725% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -8303.043% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -1252020.862% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 2410038.507% |
| Mesoblast Limited | -35.16 Million USD | 2440.179% |
| Marizyme, Inc. | 457.7 Thousand USD | -179710.007% |
| Genus plc | 178.7 Million USD | -360.545% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -273.911% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -1322488.629% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -200549.495% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 7481863.636% |
| ContraFect Corporation | -154 Thousand USD | 534511.688% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 1646088.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -1072051.223% |
| IMV Inc. | -962.29 Thousand USD | 85623.819% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 212485.0% |
| MultiCell Technologies, Inc. | 49.32 USD | -1668681976.237% |
| ONE Bio Corp. | 20.12 Million USD | -3989.322% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -1943.944% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -1682914.315% |
| Q BioMed Inc. | -8988.00 USD | 9156686.56% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -2812.738% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 5335901.349% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -1755.353% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 72193.044% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -1175605.714% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 16619526.494% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 844066.569% |
| GB Sciences, Inc. | -624.00 USD | 131890164.103% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 956758.297% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 395670292.308% |
| Enzolytics Inc. | 30.7 Thousand USD | -2679963.827% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -170492.393% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 25.755% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 160056.852% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -133203.422% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | -100.949% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 9293166.847% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 981619.159% |
| Kadimastem Ltd | -630.13 Thousand USD | 130705.359% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -83200.59% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 6953999.451% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -466027.096% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -60541.657% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 2838010.345% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -182770.081% |
| SYBLEU INC | 11.69 Thousand USD | -7036442.408% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -17760.113% |
| Bioxytran, Inc. | -8285.00 USD | 9933642.547% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 220741.823% |
| Neutra Corp. | 14.33 Thousand USD | -5741051.029% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1003751.22% |
| PureTech Health plc | -1.6 Million USD | 51440.861% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 82297.804% |
| IXICO plc | 3.27 Million USD | -25068.012% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 118687.032% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 46051.647% |
| CSL Limited | 7.7 Billion USD | 89.319% |
| Cellectis S.A. | 18 Thousand USD | -4572088.889% |